Startups
2007
TRANSBIOMED SL/ADVANCED MARKER DISCOVERY SL/AMADIXIdentify leading diagnostic biomarkers with high potential for implementation in clinical practice.
Company sold in 2016 to Amadix (http://www.amadix.com/)
Company sold in 2016 to Amadix (http://www.amadix.com/)
Address
Calle Acera de Recoletos 2, 47004 Valladolid, Spain
Finance Data
CERCA ownership
Barcelona, Spain
2002
Vall d’Hebron Institut de Recerca (VHIR)
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
Amadix has a pipeline of innovative and non-invasive tests under development for screening and early diagnostic uses in colon, lung and pancreatic cancer. The company has conducted clinical studies in more than twenty hospitals for different types of cancer. All Amadix products are duly protected by patents worldwide, with patent protection in eleven territories including the US, Europe and Japan
Company Closed or Exit Year